Education
About Us
Working with TipRanks
Follow Us
Tom Tamberrino Insider Profile
4 Followers
Tom Tamberrino, Chief Commercial Officer at Profound Medical, holds 25.33K shares in Profound Medical (Ticker: TSE:PRN). Most recently, Tom Tamberrino Bought C$12,000 shares of Profound Medical on May 17, 2025 for an estimated value of 49.67K.
Tom Tamberrino Profound Medical (PRN)Chief Commercial Officer
Profound Medical (PRN)
Chief Commercial Officer
Ranked #57,364 out of 102,596 Corporate Insiders
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
-6.30%
Average return per transaction
Time Frame
Compare to
Insider Roles
Chief Commercial Officer
Roles that Tom Tamberrino holds in companies
Most Profitable Insider Trade
The most profitable trade made by Tom Tamberrino
Tom Tamberrino's Trading History
List of latest transactions for each holding click on a transaction to see Tom Tamberrino's performance on stock
You May Also Like
Tom Tamberrino insider profile FAQ
What is the percentage of profitable transactions made by Tom Tamberrino?
The percentage of profitable transactions made by Tom Tamberrino is 50%.
What is the average return per transaction made by Tom Tamberrino?
The average return per transaction made by Tom Tamberrino is -6.30%.
What stocks does Tom Tamberrino hold?
Tom Tamberrino holds: TSE:PRN stocks.
What was Tom Tamberrino’s latest transaction?
Tom Tamberrino latest transaction was an Informative Buy of C$49.67K.
What was Tom Tamberrino's most profitable transaction?
Tom Tamberrino’s most profitable transaction was an Informative Buy of TSE:PRN stock on May 17, 2025. The return on the trade was 15.50%.
What is Tom Tamberrino's role in Profound Medical?
Tom Tamberrino's role in Profound Medical is Chief Commercial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.